Description
CABOTIB 40 Tablet 30’s cabotib 40 tablets 30’s is a specialized medication designed for individuals undergoing cancer treatment. Each tablet contains 40 milligrams of Cabozantinib, a potent inhibitor of multiple receptor tyrosine kinases. This drug is primarily indicated for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma. By targeting these specific kinases, Cabotib helps to inhibit tumor growth and angiogenesis, thereby improving outcomes for patients with these types of cancer. The recommended dosage is one tablet taken orally once daily. Always consult with a healthcare professional before starting any new medication.
Reviews
There are no reviews yet.